Healthcare, biotechnology & medical AI Product
Annalise Enterprise sends study-level alerts for selected chest X-ray findings
Annalise Enterprise is chest X-ray triage software. Its 2025 FDA filing describes alerts across five specified suspected findings, including pneumothorax and pleural effusion. [1][2]
What it does
The FDA cleared Annalise Enterprise CXR Triage Pneumothorax in February 2022, then issued a separate Annalise Enterprise clearance in April 2025. [1][2]
Why it matters
The later submission describes a defined set of additional findings beyond the earlier pneumothorax filing. The submission number distinguishes the U.S. scopes. [1][2]
Who it’s for
The intended users are trained clinicians who interpret chest radiographs in medical settings. [1][2]
Key dates
Where it fits
The software sends study-level notifications to imaging or order-management systems to help prioritize the worklist. [1][2]
Limits and trade-offs
The cited U.S. filings cover the listed findings and supported chest radiographs. The software is labeled for triage and notification. [1][2]
Sources and verification
Catalog evidence checked How we verify records
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.